1. Normetanephrine was measured in small samples of plasma and urine of hypertensive patients and normal volunteers (age 20-60 years) by a specific radioenzymatic assay with bovine adrenal phenylethanolamine N-methyltransferase and tritiated S-adenosylmethionine.
Introduction
The 25-4096 prevalence rate of raised plasma noradrenaline in primary hypertension is evidence for sympathetic nerve hyperactivity as a pathoCorrespondence: Dr Vincent DeQuattro, Hypertension Service, Department of Medicine, University of Southern California School of Medicine, Los Angeles, California 90033, U.S.A. genic factor in those patients (DeQuattro & Chan, 1972; Cousineau, DeChamplain & Lapointe, 1978; Brecht & Schoeppe, 1978; Miura, Kobayashi, Sakuma, Tomioka, Adachi & Yoshinaga, 1978) . Since 0-methylation is the chief route of metabolism of noradrenaline released into the neural cleft, the measurement of normetanephrine in plasma and urine should provide further assessment of 'active" noradrenaline (Kopin & Gordon, 1962) . In this paper we report our findings of normetanephrine concentrations in plasma, and normetanephrine excretion rates, of age-matched normotensive and hypertensive subjects determined with a new specific radioenzymatic assay for normetanephrine developed in our laboratory.
Methods

Study population and protocol
The subjects were 27 patients (20 males and seven females) with uncomplicated primary hypertension, age 2&60 years, and age-matched normotensive subjects (1 1 males and 10 females) who were paramedical personnel, members of their families, and friends. Patients were classified as hypertensive if supine blood pressure on three consecutive visits were averaged as 140/90 mmHg or greater. All patients were off drugs at least 4 weeks. In each group 70-75% were Caucasian. Blood pressures were taken, and blood samples were collected after supine rest of 60 min from an indwelling antecubital butterfly needle into iced tubes containing EDTA. Samples were centrifuged and stored at -2OOC before normetanephrine assay. EGTA and glutathione were added to portions of plasma before storage for the noradrenaline assay. Twenty-four hour urine collections 174s K. Kobayashi et al.
were completed just before venous sampling and assayed for noradrenaline, adrenaline, free and total normetanephrine, creatinine and sodium.
To assess the effects of sympathetic nerve stimulation and suppression, blood samples were repeated in subsets of three and six hypertensive patients after 3 min of one-half-maximal handgrip exercise or 5 min of one-half-maximal treadmill exercise. Supine samples were repeated in the latter group after 1 month of therapy with the central aadrenoreceptor agonist, lofexidine, an analogue of clonidine. Urine and plasma studies were also performed in five and three patients with phaeochromocytoma.
Values for young ( 2 W O years) and old (41-60) hypertensive patients were compared with those of age-matched normotensive subjects. Results were expressed as the means and SEM and comparisons were made with Student's t-test for both paired and unpaired values.
Plasma assays
For normetanephrine, 1 ml of plasma was deproteinized and placed over a Dowex 50 column according to the method of Nagatsu & Udenfriend (1972) . The eluate was evaporated under a stream of N, and was reconstituted to 200 pl with HCI (1 mmolh); 50 pl was incubated in the enzymatic reaction as described below. Noradrenaline was measured by a radioenzymatic assay (Peuler & Johnson, 1977) .
Urine assays
Urine was diluted 1 to 10 with water for measurement of free normetanephrine; and of total normetanephrine; urine was hydrolysed by boiling at pH 1 for 20 minutes, and diluted I: 50. Samples (10 pl) of diluted urine or 50 p1 samples of the purified and concentrated plasma were mixed with 'H-SAM, phenylethanolamine N-methyltransferase from bovine adrenals, Tris containing EDTA, by the modified method of Henry, Starman, Johnson & .Williams (1975) . The reaction was stopped at 60 min with borate buffer (0.5 moll) and the formed [3H]metanephrine was extracted, applied to silica gel plates, developed and scraped off the plate by the method of Peuler & Johnson (1977) . The samples were counted for 'H activity. The amounts of normetanephrine present in the unknown were calculated from duplicate specimens with added internal standard. Urinary noradrenaline was measured by a fluorimetric assay (Crout, 1961) .
Results
The normetanephrine assay detected 5 pg of normetanephrine and the recovered radioactivity was linear to 500 pg. It was specific; octopamine gave 4.9% and noradrenaline, adrenaline and dopamine gave less than 1% cross-reactivity when these amines were added to the incubation mixture.
The overall recovery of normetanephrine through the plasma extraction procedure was 70%. The interassay variation for normetanephrine in pooled plasma was 11% and that for free and conjugated normetanephrine in pooled urine was 6.7%.
The plasma normetanephrine concentrations were in the range 30-120 pg/ml in normotensive subjects and 30-160 pg/ml in the hypertensive patients ( Table 1) . Values increased twofold in three normotensive subjects studied after standing for 15 min, with a slight reduction after the next 45 min. Lofexidine suppressed both plasma normetanephrine and noradrenaline by 50% in six hypertensive patients. On the other hand, treadmill or handgrip exercise increased normetanephrine and noradrenaline two-and three-fold respectively in subgroups of three and six hypertensive patients. Plasma normetanephrine and noradrenaline concentrations of young hypertensive patients were greater than those of normotensive subjects. Plasma concentrations of normetanephrine in hypertensive patients were correlated with their plasma noradrenaline ( r = 0.75, P < 0.001).
Plasma normetanephrine was increased 30-100 times in patients with phaeochromocytoma compared with values in normotensive subjects.
Mean sodium excretion was 133 mmol/day for both normotensive and hypertensive individuals. Total normetanephrine excretion rates increased with age for both hypertensive and normotensive groups ( r = 0.42, P < 0.01). The mean free and conjugated normetanephrine excretion rates of all hypertensive patients were 50 and 25% greater respectively than values for normotensive subjects (Table 1) . Mean free normetanephrine excretion was increased in older hypertensive patients compared with those of normotensive subjects.
However, mean conjugated and total normetanephrine excretion was increased significantly only in the young hypertensive groups, compared with age-matched normal subjects. Conjugated and total normetanephrine excretion was related to noradrenaline excretion in all subjects (r = 0.31, Plasma noradrenaline concentrations of all subjects were related to their conjugated normetanephrine excretion rates (r = 0.31, P < 0.05). Urinary free and conjugated normetanephrines of the patients with phaeochromocytoma were increased 5-to 50-fold compared with values for normotensive subjects.
Discussion
This new radioenzymatic method detected normetanephrine concentrations in normal human plasma in the range 30-120 pg/ml and in normal human urine in the ranges 7-50 and 50-250 ng/mg of creatinine for free and total normetanephrine respectively. Perturbations of sympathetic nerve function with upright posture and physical stress or with drugs which suppress sympathetic nervous tone were reflected by changes of plasma noradrenaline concentrations and urinary normetanephrine excretion rates as well as those of noradrenaline concentrations and urinary normetanephrine excretion rates as well as those of noradfacilitate this diagnosis in patients with noradrenaline-producing tumours. Our preliminary findings suggest that blood can be. collected under less stringent conditions of temperature than that required for noradrenaline determination. Plasma and urinary normetanephrine both tended to increase with age. In this preliminary study the concentrations of free normetanephrine and noradrenaline in plasma from resting young hypertensive patients, and the excretion rates of normetanephrine of the same subjects while ambulatory without standardized physical activity, were both greater than respective values of agematched normotensive subjects.
Newly synthesized and released transmitter is metabolized primarily by 0-methyltransferase in the region of the neural cleft (Kopin, Breese, Krauss & Weise, 1968) . Human hypertensive patients with enhanced noradrenaline synthesis and excretion have increased excretion of normetanephrine (DeQuattro, 197 1). Increased total normetanephrine excretion has also been observed in hypertensive patients on a diet with 10 mmol of sodium/day (Robertson, Shand, Hollifield, Nies, Frolich & Oates, 1979) .
The findings of raised plasma normetanephriine and increased excretion rates of conjugated normetanephrine in young patients with primary
